NKGen Biotech Competitors and Similar CompaniesClear all
NKGen Biotech's competitors and similar companies include Coherus Oncology, Foghorn Therapeutics, JW Therapeutics and ImmPACT-Bio.
 NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | ||
Founding Date | Founding Date 2017 | Founding Date 2010 | Founding Date 2016 | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Santa Ana, US HQ | Locations Redwood City, US HQ Camarillo, US | Locations Cambridge, US HQ Cambridge, US | Locations CN HQ Suzhou Shi, CN | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 7316% increase | Employees 14736% decrease | Employees 1123% decrease | Employees 106 | Employees 845% decrease |
Valuation ($) | Valuation ($) 11 m | Valuation ($) 85.6 m | Valuation ($) 452 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($44.3m) (FY, 2024) | Net income $168m (FY, 2025) | Net income ($74.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 90m (about 8 years ago) | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 11m | Total funding raised $ 174.5m | Total funding raised $ 50m | Total funding raised $ 90m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Coherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company